<?xml version="1.0" encoding="UTF-8"?>
<results title="medproc">
 <result pre="one-third of all the SARS patients required high flow oxygen" exact="therapy" post="4, 20–30% required intensive care unit (ICU) admission or"/>
 <result pre="liver, and kidneys 22. 3. Pharmacological Therapy General principles Anti-bacterial" exact="therapy" post="for community-acquired pneumonia in accordance with standard guidelines 23"/>
 <result pre="administered before laboratory confirmation of SARS-CoV infection. Where effective anti-viral" exact="therapy" post="is available, it should be started as early as"/>
 <result pre="to the immunopathological phase 5, concomitant institution of an immunomodulatory" exact="therapy" post="should also be considered 11. Since there are no"/>
 <result pre="assisted ventilation and intensive supportive treatments will be required. Antiviral" exact="therapy" post="Ribavirin was the most commonly used empirical antiviral agent"/>
 <result pre="Kong 26, 31 patients who had received Kaletra as rescue" exact="therapy" post="together with high dose corticosteroids had no difference in"/>
 <result pre="Baicalin, also demonstrates anti-SARS-CoV activity in vitro (unpublished data). Immunomodulatory" exact="therapy" post="In the absence of an effective antiviral agent in"/>
 <result pre="could sometimes occur very rapidly; immediate administration of pulsed methylprednisolone" exact="therapy" post="at 500–1000 mg per day intravenously for 2 days,"/>
 <result pre="12 patients who deteriorated despite repeated rescue methylprednisolone and ribavirin" exact="therapy" post="had shown some improvement in radiographic scores and oxygen"/>
 <result pre="12890854 52 Van den Berghe G et al. Intensive insulin" exact="therapy" post="in critically ill patients N Engl J Med 2001"/>
</results>
